Prevalence of Rubella Specific IgG Antibodies among Expectant Mothers in Two Tertiary Hospitals in Rivers state, Nigeria

Main Article Content

C. C. Adim
N. N. Odu
T. Sampson
L. O. Amadi
I. O. Okonko


Aims: Infections caused by rubella, though mild and self-limiting, can cause severe complications to newborn babies. It affects pregnant women mainly during their first trimester, invades the fetus leading to congenital rubella syndrome. This study was carried out to assess a population of pregnant women for rubella virus IgG antibodies and to determine their level of susceptibility to the viral infection in Rivers State.

Study Design: Cross-sectional study.

Place and Duration of Study: University of Port Harcourt Teaching Hospital (UPTH) and Rivers State University Teaching Hospital (RSUTH), both in Rivers State, Nigeria, between June 2019 and June 2020.

Methodology: Two hundred and seventy (270) consenting pregnant women, attending Rivers State University Teaching Hospital and University of Port Harcourt Teaching Hospital, were randomly assessed for the study. The sera were analyzed for detectable anti-rubella virus IgG antibody following the manufacturer’s description using ELISA kits.

Results: Of the 270 samples evaluated for rubella Immunoglobulin G antibody, 241 (89.3%) were positive and 29 (10.7%) were negative. Rubella IgG seroprevalence was not associated with age, gestational stage, occupation and education.

Conclusion: The level of rubella IgG among the pregnant women in Rivers State was highly suggestive of exposure with several bouts of the viral infection. Therefore, there is an urgent need to improve Rubella infection surveillance, create awareness and organize Rubella screening for pregnant women.

IgG antibody, rivers state, pregnant women, rubella

Article Details

How to Cite
Adim, C. C., Odu, N. N., Sampson, T., Amadi, L. O., & Okonko, I. O. (2020). Prevalence of Rubella Specific IgG Antibodies among Expectant Mothers in Two Tertiary Hospitals in Rivers state, Nigeria. Asian Research Journal of Gynaecology and Obstetrics, 4(1), 13-19. Retrieved from
Original Research Article


Chen MH, Icenogle JP. Rubella virus capsid protein modulates viral genome replication and virus infectivity. J. Virol. 2004;78:4314-4322.

Best JM, Samantha C, Banatvala, JE. Rubella virus. In Topley & Wilson’s Microbiology and Microbial Infections. Virology. 10th Ed. 2005;959-992.

Weinberg J, Brownlee J. Infectious Diseases: Rubella. Infectious Disease Advisor Online; 2019.

Atkinson W. Epidemiology and Prevention of Vaccine-Preventable Diseases 12th Ed. Public Health Foundation. 2011;301-323.

Huong M. Infectious diseases related to travel. CDC health information for international travel. The yellow book; 2014.

Matthew LA, Lawrence LM, Gray D, Gray S. An audit of rubella IgG antibody status in antenatal women in a NHS Trust over 5 years. Epidemiol. Infect. 2011;319(11): 1720-1726.

Pankhurst CL, Coulter WA. Basic guide to infection prevention and control in dentistry. 2017;2(3):41.

Lambert N, Strebel P, Orenstein W, Icenogle J. Rubella. Lancet. 2015; 385(9984):2297-2307.

Atreya CD, Mohan KV, Kulkarni S. Rubella virus And Birth Defects: Molecular insight into the viral teratogenesis at the cellular level. Birth Defects Research Part A Clin. Mol. Tera. 2004;70(7):431-437.

Mehta NM, Thomas RM. Antenatal screening for rubella-infection or immunity? Biomed. J. 2002;325(7355):90-91.

WHO. WHO position paper on rubella vaccines. Weekly Epidemiology Record. 2000;75:161-172.

Kolawole OM, Anjorin EO, Adekanle DA, Kolawole CF, Durowade KA. Seroprevalence of rubella IgG antibody in pregnant women in Osogbo, Nigeria. Int. J. Prev. Med. 2014;5(3):287-292.

Mangga HK, Aminu M, Inabo HI. Seroprevalence of Rubella Specific IgG Antibody among Pregnant Women Attending Ante-Natal Clinics in Kaduna Metropolis, Nigeria. Nig. J. Basic Appl. Sci. 2014;22(3&4):63-66.

Adewumi OM, Olayinka OA, Olusola BA, Faleye TO, Sule WF, Adesina O. Epidemiological Evaluation of Rubella Virus Infection among Pregnant Women in Ibadan, Nigeria. Journal of Immunoassay and Immunochemistry 2015;36(6):613–621.

Kuta FA, Usman SS, Abalaka, ME, Bala, JD, Adabara, NU, Adedeji AS. Seroprevalence of IgG Antibodies Against Rubella Virus Infection BJMLS. 2017;2(1): 93-101.

Yahaya H, Ibrahim A, Ahmad IM, Yunusa I. Rubella prevalence in Nigeria (1977–2015): An updated review on the impact. Annal of Experimental Biology 2017;5(2):15-21.

Bamgboye AE, Afolabi KA, Esumeh FI, Enweani IB. Prevalence of rubella antibody in pregnant women in Ibadan, Nigeria. W. Afr. J. Med. 2004;23,245-248.

Olajide O, Aminu M, Randawa AJ, Adejo DS. Seroprevalence of rubella-specific IgM and IgG antibodies among pregnant women seen in a tertiary hospital in Nigeria. Int. J. Women Health. 2015;(7):75-83.

Araoye MO. Research methodology with statistics for health and social science. Sample size determination. Nathadex publishers. 2004;118 121.

Mohammed DA, Shittu O, Sadauki H, Olayinka A, Kolawole B, Adejo D. Prevalence of rubella IgG antibodies among pregnant women in Zaria, Nigeria. Int. Health. 2010;2(2):156–159.

Wondimeneh Y, Tiruneh M, Ferede G, Aberab B, Workinehc M, Birhanied M, Tessema B. Rubella virus infections and immune status among pregnant women before the introduction of rubella vaccine in Amhara Regional State, Int. J. Infect. Dis. 2018;76,14-22.

Dromigny JA, Nabeth P, Perrier G, Claude JD. Evaluation of the seroprevalence of rubella in the region of Dakar, Senegal. Trop. Med. Int. Health. 2003;8,740-743.

Fokunang CN, Chia J, Ndumbe P, Mbu P, Atashili J. Clinical studies on seroprevalence of rubella virus in pregnant women of Cameroon regions. Afri. J. Clin. Exp. Microbiol. 2010;11(2):79–94.

Jonas A, Cardemil CV, Beukes A, Anderson R, Rota PA, Bankamp B. Rubella immunity among pregnant women aged 15-44 years, Namibia. Int. J. Infect. Dis. 2016;49,196-201.

Adewumi MO, Olusanya RB, Oladunjoye BA, Adeniji JA. Qualitative and quantitative analysis of rubella IgG Antibody among Pregnant Women in Ibadan, Nigeria. Afri. J. Clin. Exp. Microbiol. 2013;14(1):40-44.

Gubiu AB, Olonitola S, Jattau E, Mukhtar MA. Sero-Prevalence of rubella virus among pregnant women in Kaduna State Nigeria 2015. J. Publ. Heal. Inform. 2017; 9(1):185.

Agbede OO, Adeyemi OO, Olatinwo AW, Salisu TJ, Kolawole OM. Sero- Prevalence of Antenatal Rubella in UITH. Open Publ. Heal. J. 2011;4:10-16.

Onakewhor JU, Chiwuzie J. Seroprevalence survey of rubella infection in pregnancy at the University of Benin Teaching Hospital, Benin City, Nigeria. Niger. J. Clin. Pract. 2011;14(2):140- 145.

Ekuma UO, Ogbu O, Okolo MO, Edeh PA, Eda OE, Nkwoemeka NE. Seroprevalence Survey of Rubella IgG Antibodies among Pregnant Women Attending Antenatal Clinics in Abakaliki, Ebonyi State, Nigeria. Umyu. J. Microbiol. Res. 2018;3(2):50-55.

Junaid SA, Akpan KJ, Olabode AO. Sero survey of rubella IgM antibodies among children in Jos, Nigeria. Virol. J. 2011;8,244-248.

Bukbuk DN, El-Nafaty AU, Obey JY. Prevalence of rubella-specific IgG antibody in non-immunized pregnant women in Maiduguri North-Eastern Nigeria. Cent. Eur. J. Publ. Heal. 2002;10(1-2):21-23.

Ogbonnaya EC, Chinedum EK, Amajor J, Amajor E. Survey of the seroprevalence of IgM antibodies in pregnant women infected with rubella virus. J. Biotech. Pharm. Res. 2012;3(1):10-14.